Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1955 1
1956 1
1963 1
1968 2
1969 2
1970 1
1971 7
1972 4
1973 4
1974 3
1975 1
1976 3
1977 8
1978 8
1979 7
1980 7
1981 3
1982 10
1983 7
1984 6
1985 6
1986 11
1987 6
1988 10
1989 6
1990 10
1991 8
1992 6
1993 14
1994 12
1995 12
1996 18
1997 12
1998 14
1999 15
2000 19
2001 13
2002 15
2003 20
2004 11
2005 7
2006 8
2007 7
2008 10
2009 8
2010 11
2011 12
2012 9
2013 23
2014 17
2015 16
2016 19
2017 13
2018 25
2019 24
2020 20
2021 21
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

555 results
Results by year
Filters applied: . Clear all
Page 1
PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ. Latchman Y, et al. Among authors: iwai y. Nat Immunol. 2001 Mar;2(3):261-8. doi: 10.1038/85330. Nat Immunol. 2001. PMID: 11224527
Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.
Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, Yamanaka K, Sato Y, Jokura H, Yomo S, Nagano O, Kenai H, Moriki A, Suzuki S, Kida Y, Iwai Y, Hayashi M, Onishi H, Gondo M, Sato M, Akimitsu T, Kubo K, Kikuchi Y, Shibasaki T, Goto T, Takanashi M, Mori Y, Takakura K, Saeki N, Kunieda E, Aoyama H, Momoshima S, Tsuchiya K. Yamamoto M, et al. Among authors: iwai y. Lancet Oncol. 2014 Apr;15(4):387-95. doi: 10.1016/S1470-2045(14)70061-0. Epub 2014 Mar 10. Lancet Oncol. 2014. PMID: 24621620
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T. Freeman GJ, et al. Among authors: iwai y. J Exp Med. 2000 Oct 2;192(7):1027-34. doi: 10.1084/jem.192.7.1027. J Exp Med. 2000. PMID: 11015443 Free PMC article.
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Among authors: iwai y. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
Caged Bird.
Iwai Y. Iwai Y. Acad Med. 2021 Jun 1;96(6):849. doi: 10.1097/ACM.0000000000003817. Acad Med. 2021. PMID: 33149088 No abstract available.
Abolition medicine.
Iwai Y, Khan ZH, DasGupta S. Iwai Y, et al. Lancet. 2020 Jul 18;396(10245):158-159. doi: 10.1016/S0140-6736(20)31566-X. Lancet. 2020. PMID: 32682471 Free PMC article. No abstract available.
555 results